Skip Ribbon Commands
Skip to main content

Pharma RFP/Invitation Notices

Terms and Conditions: 

  1. All RFP proposals must be submitted through the Ariba sourcing tool.
  2. Your company must be registered in Singapore to participate in ALPS events.
  3. For all events, the Supply Head requirement for participation is EPU/DAP/32.
  4. Each Company must participate at all sourcing events through or using the same Ariba account. 

You can gain direct access into events by following the steps outlined below:
  • Click on the respective link found in the column “Respond to Posting”. You will be directed to the next page
  • Click on the “Respond to Posting” button found on the page
  • Log in to Ariba by entering your Ariba ID and password
  • You will gain access into the event for proposal submission
  • Submit your proposal in the Ariba sourcing tool before the closing date and time stated in the RFP notice below ​ 

Contact Persons:

Chua Chye Juan (Tel: 6377 8733)
Maimunah ​Abdul Rahman (Tel: 6377 8732)
Nor'ain Mohd Yusoff (Tel: 6377 8734)  ​

Purchasing Programme

Evaluation Criteria

Evaluation Criteria (Unregistered Drugs)

RFP Results (Updated on 15 November 2019)


RFP/Invitation Notices

  
Event Description
  
  
  
  
  
  
Remarks
GPOR 40119
Item 1 - Omeprazole 40mg Injection
Item 2 - Pantoprazole 40mg Injection
GPOR 4011915/11/20196/12/2019 12:00 PMhttp://discovery.ariba.com/rfx/7530581S5 or HigherNo
GPOR 40019

​Item 1 - Esomeprazole 40mg Injection

GPOR 4001915/11/20196/12/2019 12:00 PMhttp://discovery.ariba.com/rfx/7530575S3 or HigherNo
GPOR 39919
Item 1 - Aprepitant 80mg Capsules
Item 2 - Aprepitant 125/80mg Tri-Capsule Pack
Item 3 - Netupitant 300mg and Palonosetron 0.5mg Capsules
GPOR 3991915/11/20196/12/2019 12:00 PMhttp://discovery.ariba.com/rfx/7530560S4 or HigherNo
GPOR 39819
Item 1 - Calfactant 105mg/3ml Intratracheal Suspension
Item 2 - Calfactant 210mg/6ml Intratracheal Suspension
GPOR 3981915/11/20196/12/2019 12:00 PMhttp://discovery.ariba.com/rfx/7530539S2 or HigherNo
GPOR 39719

​Item 1 - Pentoxifylline 400mg Extended-Release Tablets

GPOR 3971915/11/20196/12/2019 12:00 PMhttp://discovery.ariba.com/rfx/7530519S2 or HigherNo
GPOR 39619

​Item 1 - Omalizumab 150mg Injection

GPOR 3961915/11/20196/12/2019 12:00 PMhttp://discovery.ariba.com/rfx/7530505S2 or HigherNo
GPOR 39519

​Item 1 - Epoprostenol for Injection, 1.5mg/vial

GPOR 3951915/11/20196/12/2019 12:00 PMhttp://discovery.ariba.com/rfx/7530490S2 or HigherNo
GPOR 39419

​Item 1 - Rituximab 100mg/10ml Injection 
Item 2 - Rituximab 500mg/50ml Injection
Item 3 - Rituximab 1400mg/11.7ml Injection

GPOR 3941908/11/201929/11/2019 12:00 PMhttp://discovery.ariba.com/rfx/7439253S8 or HigherNo
GPOR 39319

​Item 1 - Alglucosidase Alfa for Injection, 50mg/vial

GPOR 3931901/11/201922/11/2019 12:00 PMhttp://discovery.ariba.com/rfx/7464317S2 or HigherNo
GPOR 39219

​Item 1 – Anti-D Blood Grouping Serum (RH 1), 10ml bottle

GPOR 3921901/11/201922/11/2019 12:00 PM http://discovery.ariba.com/rfx/7474396S2 or HigherNo